NCT04626895View on ClinicalTrials.gov

Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

October 1, 2020

Conditions
Breast CancerOvarian CancerGynecologic NeoplasmEndometrial Cancer
Interventions
DEVICE

Paxman Scalp Cooling Device

Paxman scalp cooling device

Trial Locations (1)

20010

MedStar Washington Hospital Center, Washington D.C.

Sponsors

Collaborators (1)

Paxman
All Listed Sponsors
collaborator

Paxman

UNKNOWN

lead

Medstar Health Research Institute

OTHER

NCT04626895 - Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers | Biotech Hunter | Biotech Hunter